×

Europe Top News and Analysis Denmark

  • *California drug pricing initiative also heading for defeat. *EpiPen maker Mylan jumps 8 percent in Tel Aviv. LONDON, Nov 9- Pharmaceutical stocks leapt on Wednesday as Republican Donald Trump's U.S. presidential election win led investors to conclude the threat of tough action on drug pricing had receded.

  • *California drug pricing initiative also heading for defeat. *EpiPen maker Mylan soars 8 percent in Tel Aviv. LONDON, Nov 9- Pharmaceutical stocks surged in Europe on Wednesday as Republican Donald Trump's U.S. presidential election win led investors to conclude the threat of tough action on drug pricing had receded.

  • By Nikolaj Skydsgaard and Jacob Gronholt-Pedersen. COPENHAGEN, Nov 8- Danish energy group DONG Energy plans to quit the oil and gas business to focus solely on offshore wind power, just five months after giving the impression it would maintain its presence in oil and gas when it listed in Copenhagen. Chief Executive Henrik Poulsen said on Tuesday DONG had spent...

  • COPENHAGEN, Nov 8- Danish energy group DONG Energy plans to quit the oil and gas business to focus solely on offshore wind power, adding to billions of dollars of North Sea oil and gas assets already up for sale. "We want to get to the right transaction, that obviously provides value to shareholders and provides the oil and gas business with the right long term...

  • A Maersk Line container ship is unloaded and refueled at the Port of Los Angeles in San Pedro, Calif.

    Moller-Maersk Group, the world's largest shipping company by capacity, announced a slump in third-quarter profits on Wednesday due to low freight prices.

  • Denmark is already suffering from the fall in sterling.

  • *No. 1 insulin maker halves profit growth forecast. COPENHAGEN, Oct 28- Top insulin maker Novo Nordisk slashed its long-term profit growth forecast on Friday, signalling no let-up in its struggles to crack the U.S. market to which its chief executive said its commitment would not waver. The Danish firm's shares fell by as much as 19 percent to a 30- month low, wiping...

  • COPENHAGEN, Oct 27- The Panama Canal is likely to attract up to 15 percent more tonnage next year after an upgrade which means it can now accommodate gas tankers previously too large to transit, its operator said on Thursday. The expanded canal opened in June, fitted with new locks that allow ships three times bigger than previously to pass through.

  • COPENHAGEN, Oct 27- The Panama Canal is likely to attract up to 15 percent more tonnage next year after an upgrade which means it can now accommodate gas tankers previously too large to transit, its operator said on Thursday. The expanded canal opened in June, fitted with new locks that allow ships three times bigger than previously to pass through.

  • COPENHAGEN Oct 27- Container shipping firm Islamic Republic of Iran Shipping Lines expects to have regained by the middle of next year the business lost while Iran was subject to international sanctions, its chairman said on Thursday. International sanctions were lifted in January following an agreement with world powers on Tehran's disputed nuclear...

  • COPENHAGEN Oct 27- Container shipper Islamic Republic of Iran Shipping Lines Chairman Mohammad Saeidi expects the firm to have recuperated by the middle of next year the business lost while Iran was subject to international sanctions. "Step by step the problems have been resolved, removing many restrictions and limitations," since the sanctions were lifted,...

  • LONDON, Oct 26- Gold was little changed on Wednesday but analysts expect further gains after a retreat in the dollar and signs of healthy physical demand. "We've seen the dollar rally halted and that may give gold some additional room to manoeuvre to the upside, so I'm quietly constructive for gold," said Ole Hansen, head of commodity strategy at Saxo Bank in...

  • COPENHAGEN, Oct 26- Other container shipping firms may join Hanjin Shipping Co Ltd in receivership before the industry emerges from its current shakeout, the vice chairman of world number three player CMA CGM said on Wednesday. South Korea's Hanjin filed for protection from creditors in late August, stranding $14 billion in cargo and sending shockwaves...

  • LONDON, Oct 26- Gold steadied on Wednesday, largely holding on to gains from the previous session spurred by a retreat in the dollar and healthy physical demand. "We've seen the dollar rally halted and that may give gold some additional room to maneuver to the upside so I'm quietly constructive for gold," said Ole Hansen, head of commodity strategy at Saxo Bank in...

  • *Egypt short for dollars, container shippers in downturn. COPENHAGEN, Oct 25- Egypt is in talks with global shipping firms to change the way it charges vessels to pass through the Suez Canal, offering discounts for advance payments as it seeks to raise much-needed hard currency from a struggling industry. Egypt aims to double its revenue from the Canal by 2023 with...

  • *Iraq says it should be exempt from OPEC output curbs. NEW YORK, Oct 24- Oil prices fell as much as 2 percent on Monday on news of the impending restart of Britain's Buzzard oilfield, and U.S. crude slid below $50 per barrel, which triggered technical selling. Earlier, oil was pressured by news that Iraq wanted to be exempt from a production cut by the Organization of the...

  • Oct 10- New data is likely to prompt doctors to abandon Bristol-Myers Squibb's immunotherapy Opdivo in favor of Merck& Co's rival Keytruda in a large segment of the lucrative lung cancer market, analysts said on Monday. It generated $840 million of sales in the second quarter, more than double those of Keytruda. Details of the trial unveiled at the European...

  • *Race is on for immunotherapy combinations in lung cancer. COPENHAGEN, Oct 10- Evelyn O'Flynn still has lung cancer. Data presented at the European Society for Medical Oncology congress suggest her early treatment with immunotherapy, as part of a clinical trial in Britain, will become standard for a growing number of patients.

  • COPENHAGEN, Oct 8- The failure of Bristol-Myers Squibb's blockbuster Opdivo immunotherapy in previously untreated lung cancer patients has opened up the market for AstraZeneca, its chief executive believes. Soriot is in Copenhagen for the European Society for Medical Oncology congress, where he and his team will be scouring data from competitors to...

  • COPENHAGEN, Oct 8- An experimental Novartis pill given with an older drug kept advanced breast cancer in check far longer than standard treatment alone, putting it on track to challenge Pfizer's blockbuster Ibrance, data showed on Saturday. Ibrance has been quickly adopted by oncologists and is tipped by analysts to sell some $2.1 billion in 2016, according to...